An 8-Week, Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended-Release in Children and Adolescent Subjects With Bipolar Depression.
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Registrational; Therapeutic Use
- Sponsors AstraZeneca
- 30 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jun 2010 New source identified and integrated (Clinical Trials Registry - India).
- 10 Jun 2010 Additional lead trial centre and investigator identified as reported by Clinical Trials Registry - India.